Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Abbott Labs Q1 Profit Rises; Lifts FY12 Profit View - Quick Facts

RELATED NEWS
Trade ABT now with 

Abbott Laboratories (ABT: Quote) reported that its first-quarter net earnings rose to $1.24 billion or $0.78 per share, from $864 million or $0.55 per share in the same quarter last year.

Excluding Specified Items, net earnings for the quarter were $1.65 billion or $1.03 per share, up from $1.42 billion or $0.91 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $1.00 per share. Analysts' estimates typically exclude special items.

Net sales for the quarter rose to $9.46 billion from $9.04 billion in the prior year quarter. Sixteen analysts had consensus revenue estimate of $9.36 billion for the quarter.

Abbott raised its full-year 2012 ongoing earnings-per-share guidance to a range of $5.00 to $5.10 from the prior outlook of $4.95 to $5.05. Analysts expect the company to report earnings of $5.01 per share for fiscal 2012.

Click here to receive FREE breaking news email alerts for Abbott Laboratories and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that it swung to a second quarter loss, hurt by higher costs and expenses even as revenue surged 47%. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Kraton Performance Polymers, Inc. (KRA), Wednesday reported second-quarter net income of $11.1 million or $0.33 per share, up from $3.8 million or $0.12 per share last year. Adjusted earnings improved to $0.46 per share from $0.15 per share last year. Revenues for the quarter dropped to $323.8... Organic grocer Whole Foods Market, Inc. said Wednesday after the markets closed that its third quarter profit rose 6.3% from last year, as same-store sales increased 3.9%. The company's quarterly earnings per share also came in above analysts' expectations, but its quarterly sales fell shy of analyst' forecast.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.